August 17, 2017 5:49pm
Volatility jumps 32.45% as many trade the overbought to being oversold
It’s portrayed to be a platform to play shuffle the stocks and make the short-side buck
As investors get consistently wiped clean
Pre-open indications: 3 hit and 1 miss
Out and about; Biostage’s (BSTG) A historical (i.e. old) article, “Maverick investor faces legal pressure … Inside the tangled world of a Chicago 'character' known for deals, debts and conflicts.”
It’s called premium content for a reason … I define insight from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!
Others don’t even come close!
I answer one question, in which company should investors commit and keep their money.
Thursday’s results have implications to Friday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!
Henry’omics:
From the pre-open’s investor’s newsletter, “…tensions heighten between the overbought and oversold. I am … “Not into playing sector chicken.”
I also stated, “A few companies with their abject failures and their audacity to seek further funding are casting aspersions upon the sector as a whole! The issue is … the sector is gauging the remainder of August through September – a dangerous time!”
Out and about:
Maverick investor faces legal pressure. Inside the tangled world of a Chicago 'character' known for deals, debts and conflicts
September 22, 2013|By Jared S. Hopkins, Chicago Tribune reporter
Two decades ago, he was one of three young traders who made $27 million in 22 days trading the stock of a bankrupt company on the Chicago Stock Exchange, becoming known as one of "the bad boys of arbitrage."
Assessing that deal, a federal appeals court judge said that Leon "Chip" Greenblatt and his associates "may be reckless gamblers, sharpies, wise guys, and exploiters of loopholes, even violators of the letter or spirit of the rules." But, he added, they did not break a law.
The advance/decline line scenario of 43 SCGT & RT covered companies:
· The first hour was negative with an A/DL of 11/29 and 3 flats;
· The mid-day was negative with an A/DL of 14/27 and 2 flat;
· The close was negative with an A/DL of 9/30 and 4 flat;
Pre-open indications: 3 hit and 1 miss
BioLife Solutions (BLFS) closed up +$0.42 – miss;
bluebird bio (BLUE) closed down -$3.85 – hit;
Kite Pharma (KITE) closed down -$2.06 – hit;
Regenxbio (RGNX) closed down -$2.15 – hit;
Regenerative Medicine Earnings Scorecard - Q2/2017 - to date … 30 out of 43 covered – so far
http://www.regmedinvestors.com/articles/9841
Daily analytics:
U.S. stock benchmarks on Thursday finished down at least 1% as heightened concerns about President Donald Trump’s legislative agenda and news of a terrorist attack in Barcelona combined to foster selling.
The Dow dropped 274.14 points, or 1.2%, to close at 21,750.73, with all 30 components finishing in negative territory.
The Dow, which had gained 180 points over a four-day winning streak, had previously finished higher in 14 of the past 18 trading days.
The S&P 500 dropped 38.10 points, or 1.5%, to finish at 2,430.01. All 11 of the S&P 500’s sectors closed lower on the session, which has only happened two other times this year.
The NASDAQ fell 123.19 points, or 1.9%, to close at 6,221.91.
The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded 15.55, up +32.45% … WOW
Wednesday traded at 11.74, down -2.49% after Tuesday traded at 12.04, down -2.35%, Monday traded at 12.38 and was down -20.18% …Friday traded at 15.51, down -3.20% following last Thursday’s 16.04, a +44.37% increase
Welcome to another day of the sector’s roller coaster …
… The iShares Russell 2000 (IWM) indicated:
· Thursday was down -1.80%
· Wednesday +0.04%
· Tuesday -0.81%
· Monday +1.49%
· Friday +0.15%
· Last Thursday -1.82%
… The iShares NASDAQ Biotechnology (IBB) indicated:
· Thursday was down -1.70%
· Wednesday +0.25%
· Tuesday +0.09%
· Monday +1.03%
· Friday +0.64%
· Last Thursday -2.82%
The count - decliners versus gainers:
……. look at the differences in the spreads as decliners jump and %
· Thursday’s decliners ranged from -0.48% <BCLI> to -9.71% <RGNX> in 30 equities;
· Wednesday’s decliners ranged from -0.31% <BSTG> to -5.36% <SGMO> in 21 equities;
· Tuesday’s decliners ranged from -0.38% <FCSC> to -15.29% <BSTG> in 24 equities;
· Monday’s decliners ranged from -0.24% <RGNX> to -17.71% <BSTG> in 12 equities;
· Friday’s decliners ranged from -0.46% <KITE> to -11.97% <IMUC> in 14 equities;
· Last Thursday’s decliners ranged from -0.31% <KITE> to -11.52% <VSTM> in 33 equities;
Versus
… Look at the percentage’s (%) and spreads …
· Thursday’s gainers ranged from +0.23% <QURE> to +14.33% <IMUC> in 9 equities;
· Wednesday’s gainers ranged from +0.05% <BLUE> to +7.44% <IMUC> in 21 equities;
· Tuesday’s gainers ranged from +0.43% <XON> to +6.08% <MDXG> in 15 equities;
· Monday’s gainers ranged from +0.88% <ADRO> to +26% <IMUC> in 28 equities;
· Friday’s gainers ranged from +0.06% <BSTG> to +11.43% <CUR> in 28 equities;
· Last Thursday’s gainers ranged from +0.32% <OSIR> to +12.43% <SGMO> in 8 equities;
Some of MY working trend lines or indications:
… The greatest volume to the downside: MDXG, SGMO, XON, JUNO and BSTG
… Upside volume was weighted to: IMUC, BLFS, AGTC, AXGN and QURE
… Biggest $ downside: BLUE, ONCE, RGNX, KITE and MDXG
… Largest $ upside: BLFS, AXGN, MESO, AGTC and IMUC
… Flat: RENE.L, HSGX, ISCO and ATHX
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
